表紙:避妊具の世界市場:業界分析、規模、シェア、成長、動向、予測(2021~2028年)
市場調査レポート
商品コード
1067985

避妊具の世界市場:業界分析、規模、シェア、成長、動向、予測(2021~2028年)

Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

出版日: | 発行: Transparency Market Research | ページ情報: 英文 189 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
避妊具の世界市場:業界分析、規模、シェア、成長、動向、予測(2021~2028年)
出版日: 2022年01月21日
発行: Transparency Market Research
ページ情報: 英文 189 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の避妊具市場について調査分析し、市場概要、製品・流通チャネル・地域別市場分析、競合情勢に関する情報を提供しています。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー:世界の避妊具市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 主要な市場指標
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界の避妊具市場の分析と予測(2017~2028年)
    • 市場収益予測(100万米ドル)
  • 世界の避妊具市場-世界の需給シナリオ
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 市場の見通し

第5章 世界の避妊具市場の分析と予測:製品別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 主要動向
  • 市場金額予測:製品別(2017~2028年)
    • 避妊薬
    • 避妊器具
  • 市場魅力分析:製品別

第6章 世界の避妊具市場の分析と予測:流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 主要動向
  • 市場金額予測(2017~2028年):流通チャネル別
    • 病院薬局
    • 独立した薬局
    • オンラインプラットフォーム
    • クリニック
    • その他
  • 市場魅力分析:流通チャネル別

第7章 世界の避妊具市場分析と予測:地域別

  • 主な調査結果
  • ポリシーと規制
  • 市場金額予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:国/地域別

第8章 北米の避妊具市場の分析と予測

  • イントロダクション
    • 主な調査結果
    • ポリシーと規制
    • 主要動向
  • 市場金額予測:製品別(2017~2028年)
    • 避妊薬
    • 避妊器具
  • 市場金額予測:流通チャネル別(2017~2028年)
    • 病院薬局
    • 独立した薬局
    • オンラインプラットフォーム
    • クリニック
    • その他
  • 市場金額予測:国別(2017~2028年)
    • 米国
    • カナダ
  • 市場の魅力分析
    • 製品別
    • 流通チャネル別
    • 国別

第9章 欧州の避妊具市場の分析と予測

第10章 アジア太平洋の避妊具市場の分析と予測

第11章 ラテンアメリカの避妊具市場の分析と予測

第12章 中東およびアフリカの避妊具市場の分析と予測

第13章 競合情勢

  • 市場企業-競合マトリックス(企業の階層と規模別)
  • 市場シェア分析:企業別(2020年)
  • 企業プロファイル
    • Merck & Co., Inc.
    • Cipla, Inc.
    • Allergan plc
    • Bayer AG
    • HLL Lifecare Limited
    • Mankind Pharma
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mithra Pharmaceuticals
    • Janssen Pharmaceutical Company
    • Reckitt Benckiser Group plc
図表

List of Tables

  • Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2017-2028
  • Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2017-2028
  • Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

List of Figures

  • Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2017-2028
  • Figure 02: Global Contraceptives Market Value Share, by Product (2020)
  • Figure 03: Global Contraceptives Market Value Share, by Distribution Channel, 2020
  • Figure 04: Global Contraceptives Market Value Share, by Region, 2020
  • Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 06: Global Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2028
  • Figure 08: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Drugs, 2017-2028
  • Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2028
  • Figure 10: Global Contraceptives Market Attractiveness Analysis, by Oral Contraceptives, 2017-2028
  • Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2028
  • Figure 12: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Devices, 2017-2028
  • Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2028
  • Figure 14: Global Contraceptives Market Attractiveness Analysis, by Female Contraceptive Devices, 2017-2028
  • Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2017-2028
  • Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2017-2028
  • Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 18: Global Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2017-2028
  • Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2017-2028
  • Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2017-2028
  • Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2017-2028
  • Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2028
  • Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2028
  • Figure 25: Global Contraceptives Market Attractiveness Analysis, by Region, 2017-2028
  • Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 27: North America Contraceptives Market Attractiveness Analysis, by Country 2017-2028
  • Figure 28: North America Contraceptives Market Value Share, by Country, 2017 and 2028
  • Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 30: North America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 32: North America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2028
  • Figure 34: Europe Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 35: Europe Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2028
  • Figure 37: Europe Contraceptives Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 39: Europe Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 41: Asia Pacific Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 42: Asia Pacific Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 44: Asia Pacific Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 46: Asia Pacific Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 48: Latin America Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 49: Latin America Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 51: Latin America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 53: Latin America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 55: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 58: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 60: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 61: Global Contraceptives Drugs Market Share, by Company, 2020
  • Figure 62: Global Contraceptives Devices Market Share, by Company, 2020
目次
Product Code: TMRGL344

TMR's report on the global contraceptives market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global contraceptives market for the period 2017-2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global contraceptives market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global contraceptives market.

The report delves into the competition landscape of the global contraceptives market. Key players operating in the global contraceptives market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global contraceptives market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of product companies in the global contraceptives market?
  • What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global contraceptives market?
  • Will North America to be the most profitable market for contraceptives devices providers?
  • Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
  • Which are the leading companies in the global contraceptives market?

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Contraceptives Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Contraceptives Market Analysis and Forecast, 2017-2028
    • 4.5.1. Market Revenue Projections (US$ Mn)
  • 4.6. Global Contraceptives Market - Global Supply Demand Scenario
  • 4.7. Porter's Five Force Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Market Outlook

5. Global Contraceptives Market Analysis and Forecast, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast, by Product, 2017-2028
    • 5.4.1. Contraceptives Drugs
      • 5.4.1.1. Oral Contraceptives
        • 5.4.1.1.1. Combined Contraceptives
        • 5.4.1.1.2. Mini-pills
      • 5.4.1.2. Contraceptive Injectable
      • 5.4.1.3. Topical Contraceptive Patch
    • 5.4.2. Contraceptive Devices
      • 5.4.2.1. Male Contraceptive Devices
      • 5.4.2.2. Female Contraceptive Devices
        • 5.4.2.2.1. Female Condoms
        • 5.4.2.2.2. Contraceptive Diaphragms
        • 5.4.2.2.3. Contraceptive Sponges
        • 5.4.2.2.4. Contraceptive Vaginal Rings
        • 5.4.2.2.5. Intrauterine Devices
        • 5.4.2.2.6. Sub-dermal Contraceptives Implants
        • 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
  • 5.5. Market Attractiveness Analysis, By Product

6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast, by Distribution Channel, 2017-2028
    • 6.4.1. Hospital Pharmacy
      • 6.4.1.1. Public
      • 6.4.1.2. Private
    • 6.4.2. Independent Pharmacy
    • 6.4.3. Online Platform
    • 6.4.4. Clinics
    • 6.4.5. Others
  • 6.5. Market Attractiveness Analysis, By Distribution Channel

7. Global Contraceptives Market Analysis and Forecast, By Region

  • 7.1. Key Findings
  • 7.2. Policies and Regulations
  • 7.3. Market Value Forecast, by Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness Analysis, By Country/Region

8. North America Contraceptives Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
    • 8.1.2. Policies and Regulations
    • 8.1.3. Key Trends
  • 8.2. Market Value Forecast, by Product, 2017-2028
    • 8.2.1. Contraceptive Drugs
      • 8.2.1.1. Oral Contraceptives
        • 8.2.1.1.1. Combined Contraceptives
        • 8.2.1.1.2. Mini-pills
      • 8.2.1.2. Contraceptive Injectable
      • 8.2.1.3. Topical Contraceptive Patch
    • 8.2.2. Contraceptive Devices
      • 8.2.2.1. Male Contraceptive Devices
      • 8.2.2.2. Female Contraceptive Devices
        • 8.2.2.2.1. Female Condoms
        • 8.2.2.2.2. Contraceptive Diaphragms
        • 8.2.2.2.3. Contraceptive Sponges
        • 8.2.2.2.4. Contraceptive Vaginal Rings
        • 8.2.2.2.5. Intrauterine Devices
        • 8.2.2.2.6. Sub-dermal Contraceptives Implants
        • 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 8.3.1. Hospital Pharmacy
      • 8.3.1.1. Public
      • 8.3.1.2. Private
    • 8.3.2. Independent Pharmacy
    • 8.3.3. Online Platform
    • 8.3.4. Clinics
    • 8.3.5. Others
  • 8.4. Market Value Forecast, by Country, 2017-2028
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By Distribution Channel
    • 8.5.3. By Country

9. Europe Contraceptives Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Policies and Regulations
    • 9.1.3. Key Trends
  • 9.2. Market Value Forecast, by Product, 2017-2028
    • 9.2.1. Contraceptive Drugs
      • 9.2.1.1. Oral Contraceptives
        • 9.2.1.1.1. Combined Contraceptives
        • 9.2.1.1.2. Mini-pills
      • 9.2.1.2. Contraceptive Injectable
      • 9.2.1.3. Topical Contraceptive Patch
    • 9.2.2. Contraceptive Devices
      • 9.2.2.1. Male Contraceptive Devices
      • 9.2.2.2. Female Contraceptive Devices
        • 9.2.2.2.1. Female Condoms
        • 9.2.2.2.2. Contraceptive Diaphragms
        • 9.2.2.2.3. Contraceptive Sponges
        • 9.2.2.2.4. Contraceptive Vaginal Rings
        • 9.2.2.2.5. Intrauterine Devices
        • 9.2.2.2.6. Sub-dermal Contraceptives Implants
        • 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 9.3.1. Hospital Pharmacy
      • 9.3.1.1. Public
      • 9.3.1.2. Private
    • 9.3.2. Independent Pharmacy
    • 9.3.3. Online Platform
    • 9.3.4. Clinics
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. U.K.
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country/Sub-region

10. Asia Pacific Contraceptives Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Policies and Regulations
    • 10.1.3. Key Trends
  • 10.2. Market Value Forecast, by Product, 2017-2028
    • 10.2.1. Contraceptive Drugs
      • 10.2.1.1. Oral Contraceptives
        • 10.2.1.1.1. Combined Contraceptives
        • 10.2.1.1.2. Mini-pills
      • 10.2.1.2. Contraceptive Injectable
      • 10.2.1.3. Topical Contraceptive Patch
    • 10.2.2. Contraceptive Devices
      • 10.2.2.1. Male Contraceptive Devices
      • 10.2.2.2. Female Contraceptive Devices
        • 10.2.2.2.1. Female Condoms
        • 10.2.2.2.2. Contraceptive Diaphragms
        • 10.2.2.2.3. Contraceptive Sponges
        • 10.2.2.2.4. Contraceptive Vaginal Rings
        • 10.2.2.2.5. Intrauterine Devices
        • 10.2.2.2.6. Sub-dermal Contraceptives Implants
        • 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 10.3.1. Hospital Pharmacy
      • 10.3.1.1. Public
      • 10.3.1.2. Private
    • 10.3.2. Independent Pharmacy
    • 10.3.3. Online Platforms
    • 10.3.4. Clinics
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Latin America Contraceptives Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Policies and Regulations
    • 11.1.3. Key Trends
  • 11.2. Market Value Forecast, by Product, 2017-2028
    • 11.2.1. Contraceptive Drugs
      • 11.2.1.1. Oral Contraceptives
        • 11.2.1.1.1. Combined Contraceptives
        • 11.2.1.1.2. Mini-pills
      • 11.2.1.2. Contraceptive Injectable
      • 11.2.1.3. Topical Contraceptive Patch
    • 11.2.2. Contraceptive Devices
      • 11.2.2.1. Male Contraceptive Devices
      • 11.2.2.2. Female Contraceptive Devices
        • 11.2.2.2.1. Female Condoms
        • 11.2.2.2.2. Contraceptive Diaphragms
        • 11.2.2.2.3. Contraceptive Sponges
        • 11.2.2.2.4. Contraceptive Vaginal Rings
        • 11.2.2.2.5. Intrauterine Devices
        • 11.2.2.2.6. Sub-dermal Contraceptives Implants
        • 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 11.3.1. Hospital Pharmacy
      • 11.3.1.1. Public
      • 11.3.1.2. Private
    • 11.3.2. Independent Pharmacy
    • 11.3.3. Online Platforms
    • 11.3.4. Clinics
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Middle East and Africa Contraceptives Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Policies and Regulations
    • 12.1.3. Key Trends
  • 12.2. Market Value Forecast, by Product, 2017-2028
    • 12.2.1. Contraceptive Drugs
      • 12.2.1.1. Oral Contraceptives
        • 12.2.1.1.1. Combined Contraceptives
        • 12.2.1.1.2. Mini-pills
      • 12.2.1.2. Contraceptive Injectable
      • 12.2.1.3. Topical Contraceptive Patch
    • 12.2.2. Contraceptive Devices
      • 12.2.2.1. Male Contraceptive Devices
      • 12.2.2.2. Female Contraceptive Devices
        • 12.2.2.2.1. Female Condoms
        • 12.2.2.2.2. Contraceptive Diaphragms
        • 12.2.2.2.3. Contraceptive Sponges
        • 12.2.2.2.4. Contraceptive Vaginal Rings
        • 12.2.2.2.5. Intrauterine Devices
        • 12.2.2.2.6. Sub-dermal Contraceptives Implants
        • 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 12.3. Market Value Forecast, by End User, 2017-2028
    • 12.3.1. Hospital Pharmacy
      • 12.3.1.1. Public
      • 12.3.1.2. Private
    • 12.3.2. Independent Pharmacy
    • 12.3.3. Online Platform
    • 12.3.4. Clinics
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Country /Sub-region, 2017-2028
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East and Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (by tier and size of companies)
  • 13.2. Market Share Analysis, by Company, 2020
  • 13.3. Company Profiles
    • 13.3.1. Merck & Co., Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Financials
      • 13.3.1.3. Recent Developments
      • 13.3.1.4. Strategy
    • 13.3.2. Cipla, Inc.
      • 13.3.2.1. Overview
      • 13.3.2.2. Financials
      • 13.3.2.3. Recent Developments
      • 13.3.2.4. Strategy
    • 13.3.3. Allergan plc
      • 13.3.3.1. Overview
      • 13.3.3.2. Financials
      • 13.3.3.3. Recent Developments
      • 13.3.3.4. Strategy
    • 13.3.4. Bayer AG
      • 13.3.4.1. Overview
      • 13.3.4.2. Financials
      • 13.3.4.3. Recent Developments
      • 13.3.4.4. Strategy
    • 13.3.5. HLL Lifecare Limited
      • 13.3.5.1. Overview
      • 13.3.5.2. Financials
      • 13.3.5.3. Recent Developments
      • 13.3.5.4. Strategy
    • 13.3.6. Mankind Pharma
      • 13.3.6.1. Overview
      • 13.3.6.2. Financials
      • 13.3.6.3. Recent Developments
      • 13.3.6.4. Strategy
    • 13.3.7. Pfizer, Inc.
      • 13.3.7.1. Overview
      • 13.3.7.2. Financials
      • 13.3.7.3. Recent Developments
      • 13.3.7.4. Strategy
    • 13.3.8. Teva Pharmaceutical Industries Ltd.
      • 13.3.8.1. Overview
      • 13.3.8.2. Financials
      • 13.3.8.3. Recent Developments
      • 13.3.8.4. Strategy
    • 13.3.9. Mithra Pharmaceuticals
      • 13.3.9.1. Overview
      • 13.3.9.2. Financials
      • 13.3.9.3. Recent Developments
      • 13.3.9.4. Strategy
    • 13.3.10. Janssen Pharmaceutical Company
      • 13.3.10.1. Overview
      • 13.3.10.2. Financials
      • 13.3.10.3. Recent Developments
      • 13.3.10.4. Strategy
    • 13.3.11. Reckitt Benckiser Group plc
      • 13.3.11.1. Overview
      • 13.3.11.2. Financials
      • 13.3.11.3. Recent Developments
      • 13.3.11.4. Strategy